Health Care · Drug Manufacturers - General

GSK plc GSK

$51.76-1.01 (-1.91%)delayed quote · as of 2026-07-17 20:57 UTC

Market cap

$103.7B

Previous close

$52.77

Volume

10.2M

52-week range

$36.16 – $61.70

Verdictconfidence 8% · low

Not enough filed data to publish a verdict for GSK. The quote above is real; the verdict engine refuses to score on thin inputs rather than guess.

Key ratios

Value

P/E TTM

—

P/E NTM

—

EV/EBITDA

—

PEG

—

FCF yield

—

Growth

Revenue 3y

—

Revenue YoY

—

Expected EPS

—

Quality

Piotroski F

—

ROIC

—

ALAN GLOBAL INTELLIGENCE · alanglobalintelligence.comquote as of 2026-07-17 20:57 UTC · fundamentals · SEC EDGAR

Continue with GSK in ALAN

Full evidence trail, financial statements back a decade, valuation history, charts, and alerts.

Open in the workspace Create free account

For information and research only. Not investment advice. ALAN does not place trades or execute orders. Figures come from the sources shown and can lag the market; verify independently before making decisions. Past performance is not predictive of future results.